Cytochrome P450 catalyses the 29-carboxyl group formation of celastrol

Jiawei Zhou,Tianyuan Hu,Yuan Liu,Lichan Tu,Yadi Song,Yun Lu,Yifeng Zhang,Yuru Tong,Yujun Zhao,Ping Su,Xiaoyi Wu,Luqi Huang,Wei Gao
DOI: https://doi.org/10.1016/j.phytochem.2021.112868
IF: 3.8
2021-10-01
Phytochemistry
Abstract:<p>Celastrol, a potent anticancer and anti-obesity drug, was first isolated from <em>Tripterygium wilfordii</em> Hook. f. and it is produced in small quantities in many members of the Celastraceae family. The heterologous reconstitution of celastrol biosynthesis could be a promising method for the efficient production of celastrol and natural and unnatural derivatives thereof, yet only part of the biosynthetic pathway is known. Here, we report a cytochrome P450 monooxygenase (<em>TwCYP712K1</em>) from <em>T. wilfordii</em> that performs the three-step oxidation of friedelin to polpunonic acid in the celastrol pathway. Heterologous expression of <em>TwCYP712K1</em> showed that <em>TwCYP712K1</em> catalyses not only the transformation of friedelin to polpunonic acid but also the oxidation of <em>β</em>-amyrin or <em>α</em>-amyrin. The role of <em>TwCYP712K1</em> in the biosynthesis of celastrol was further revealed via RNA interference. Some key residues of TwCYP712K1 were also screened by molecular docking and site-directed mutagenesis. Our results lay a solid foundation for further elucidating the biosynthesis of celastrol and related triterpenoids.</p>
biochemistry & molecular biology,plant sciences
What problem does this paper attempt to address?